Delamanid: First Global Approval

Authors

Keywords

European Union, Marketing Approval, CHMP, Orphan Drug Status, Optimise Background Therapy

Journal

Volume 74, Issue 9, Pages 1041-1045

Publisher

Springer Nature

Online

2014-06-12

DOI

10.1007/s40265-014-0241-5

References

View 8 related references

Contact the author

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now